Hilary Glen
About
In The Last Decade
Hilary Glen
34 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Pulmonary and Respiratory Medicine 845
- Molecular Biology 668
- Oncology 475
- Cancer Research 453
- Surgery 105
Countries citing papers authored by Hilary Glen
This map shows the geographic impact of Hilary Glen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilary Glen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilary Glen more than expected).
Fields of papers citing papers by Hilary Glen
This network shows the impact of papers produced by Hilary Glen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilary Glen. The network helps show where Hilary Glen may publish in the future.
Co-authorship network of co-authors of Hilary Glen
This figure shows the co-authorship network connecting the top 25 collaborators of Hilary Glen. A scholar is included among the top collaborators of Hilary Glen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilary Glen. Hilary Glen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 17 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 10 | |
| 6 | 13 | |
| 7 | 20 | |
| 8 | 8 | |
| 9 | 3 | |
| 10 | 12 | |
| 11 | 11 | |
| 12 | Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial breakdown → | 688 |
| 13 | 10 | |
| 14 | 10 | |
| 15 | 150 | |
| 16 | 75 | |
| 17 | 5 | |
| 18 | 10 | |
| 19 | 20 | |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.